Levin Arthur A
- SEC CIK
- 0001181556
In the past year, 2 open-market sale filings worth $149.6K and no purchases.
Current role at each company
- STOK Stoke Therapeutics, Inc.Directoras of Jun 5, 2026
- Avidity Biosciences, Inc.Directoras of Feb 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $149.6K
- 2 filings
- Net
- −$149.6K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Levin Arthur A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
STOK Stoke Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 (view filing) | Mar 13 | 4 days | Levin Arthur ADirector | SSale | −605 | $36.80 | −$22.3K | −12.5%4.24K after | 10b5-1 |
Avidity Biosciences, Inc.
Director22 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2021 (view filing) | Nov 18 | 4 days | Levin Arthur AChief Scientific Officer | SSale | −25.0K | $27.89 | −$697.3K | −94.9%1.33K after | |
| Aug 31, 2022 (view filing) | Aug 12-16 | 19 daysLate | Levin Arthur AChief Scientific Officer | SSale | −80.0K | $22.10 | −$1.77M | −98.4%1.33K after | 3 lots |
| Jan 3, 2023 (view filing) | Dec 29, 2022 | 5 days | Levin Arthur AChief Scientific Officer | SSale | −40.0K | $22.01 | −$880.4K | −96.8%1.33K after | |
| Jan 17, 2023 (view filing) | Jan 12 | 5 days | Levin Arthur AChief Scientific Officer | SSale | −10.0K | $22.00 | −$220.0K | −88.3%1.33K after | |
| Feb 15, 2023 (view filing) | Feb 14 | 1 day | Levin Arthur AChief Scientific Officer | SSale | −10.0K | $23.65 | −$236.5K | −34.1%19.3K after | 2 lots |
| Mar 17, 2023 (view filing) | Mar 15 | 2 days | Levin Arthur ADirector | SSale | −100 | $22.01 | −$2.20K | −0.5%19.3K after | |
| Jan 23, 2024 (view filing) | Jan 22 | 1 day | Levin Arthur ADirector | SSale | −1.86K | $10.13 | −$18.8K | −9.6%17.5K after | 10b5-1 |
| Mar 12, 2024 (view filing) | Mar 12 | Same day | Levin Arthur ADirector | SSale | −27.6K | $22.04 | −$609.1K | −65.1%14.8K after | 2 lots10b5-1 |
| Mar 21, 2024 (view filing) | Mar 19 | 2 days | Levin Arthur ADirector | SSale | −5.00K | $23.97 | −$119.8K | −25.2%14.8K after | 10b5-1 |
| Apr 3, 2024 (view filing) | Apr 3 | Same day | Levin Arthur ADirector | SSale | −20.0K | $27.11 | −$542.2K | −7.3%253.9K after | 10b5-1 |